Stay updated on SMA Biomarker Study Clinical Trial
Sign up to get notified when there's something new on the SMA Biomarker Study Clinical Trial page.

Latest updates to the SMA Biomarker Study Clinical Trial page
- Check6 days agoChange DetectedThe screenshots show primarily minor UI/formatting updates with no changes to core study content such as eligibility criteria, endpoints, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated page to add the broader term 'Spinal muscular atrophy', bump revision to v3.2.0, and include an updated government operations notice replacing the previous 'Proximal spinal muscular atrophy' denomination from v3.1.0.SummaryDifference3%

- Check42 days agoChange DetectedUpdated page version to v3.1.0 and added a contact phone number; versioning changed from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. Substantive content (pricing, stock, dates/times, proper nouns) remains unchanged.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with recent publications related to proximal spinal muscular atrophy. Additionally, the version has been revised from v2.16.12 to v3.0.0.SummaryDifference9%

Stay in the know with updates to SMA Biomarker Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SMA Biomarker Study Clinical Trial page.